Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Motawi T.M.K. | |
dc.contributor.author | Zakhary N.I. | |
dc.contributor.author | Darwish H.A. | |
dc.contributor.author | Abdalla H.M. | |
dc.contributor.author | Tadros S.A. | |
dc.contributor.other | Department of Biochemistry | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | Cairo University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Department of Cancer Biology | |
dc.contributor.other | National Cancer Institute | |
dc.contributor.other | Cairo University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Board of Trustees | |
dc.contributor.other | The British University in Egypt (BUE) | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Department of Pharmacology | |
dc.contributor.other | Toxicology | |
dc.contributor.other | and Biochemistry | |
dc.contributor.other | Faculty of Pharmaceutical Sciences and Pharmaceutical Industries | |
dc.contributor.other | Future University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Department of Surgical Oncology | |
dc.contributor.other | National Cancer Institute | |
dc.contributor.other | Cairo University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Department of Biochemistry | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | October University for Modern Sciences and Arts (MSA) | |
dc.contributor.other | October | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:40:39Z | |
dc.date.available | 2020-01-09T20:40:39Z | |
dc.date.issued | 2019 | |
dc.description | Scopus | |
dc.description.abstract | The majority of breast cancer cases are discovered in later disease stages, thus affecting survival rate. We studied the impact of survivin -31 G/C single nucleotide polymorphism and its serum level alteration. Minor allele C and the GC + CC genotype occurred more frequently in breast cancer patients; further, increased breast cancer risk with associated with elevated serum survivin level. These data could help in early diagnosis and understanding of the pathogenesis of breast cancer. 2019 Elsevier Inc.Background: Breast cancer is one of the most relevant malignancies among women. Molecular abnormalities in promotor region of survivin gene may account for overexpression of survivin and increased breast cancer risk. This study aimed to explore the potential association between survivin promotor gene -31G/C single nucleotide polymorphism (rs9904341) and its serum level alteration on one hand, and the risk of breast cancer in Egyptian patients on the other hand. It also aimed to assess the usefulness of survivin as an early noninvasive diagnostic biomarker and in breast cancer staging. Patients and Methods: A total of 135 patients with physically and pathologically confirmed breast cancer and 40 unrelated control subjects as well as 40 patients with benign breast mass were recruited from the early detection unit at National Cancer Institute, Cairo University. Genotyping was performed using allelic discrimination probes by real-time quantitative PCR and serum survivin by enzyme-linked immunosorbent assay. Results: The minor allele C of -31G/C survivin single nucleotide polymorphism was more frequent in breast cancer patients (19.3%) compared to the control group (7.5%). Furthermore, subjects with the GC + CC genotype were at increased risk of breast cancer compared to the GG genotype of the control group and also the benign group. Moreover, those patients exhibited higher serum levels of survivin compared to GG genotype. There was also significant elevation of serum survivin in different breast cancer stages. Conclusion: Genetic variation in -31G/C of the survivin gene may contribute to the disposition of breast cancer in the Egyptian population. Serum survivin alteration played a pivotal role in the pathogenesis of breast cancer. 2019 Elsevier Inc. | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=29260&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/10.1016/j.clbc.2019.01.002 | |
dc.identifier.doi | PubMed ID 30765238 | |
dc.identifier.issn | 15268209 | |
dc.identifier.other | https://doi.org/10.1016/j.clbc.2019.01.002 | |
dc.identifier.other | PubMed ID 30765238 | |
dc.identifier.uri | https://t.ly/xEw3K | |
dc.language.iso | English | en_US |
dc.publisher | Elsevier Inc. | en_US |
dc.relation.ispartofseries | Clinical Breast Cancer | |
dc.relation.ispartofseries | 19 | |
dc.subject | BIRC5 | en_US |
dc.subject | Inhibitor of apoptosis proteins | en_US |
dc.subject | Promotor polymorphism | en_US |
dc.subject | survivin | en_US |
dc.subject | adult | en_US |
dc.subject | allele | en_US |
dc.subject | Article | en_US |
dc.subject | breast cancer | en_US |
dc.subject | cancer staging | en_US |
dc.subject | controlled study | en_US |
dc.subject | DNA extraction | en_US |
dc.subject | early cancer diagnosis | en_US |
dc.subject | enzyme linked immunosorbent assay | en_US |
dc.subject | female | en_US |
dc.subject | gene overexpression | en_US |
dc.subject | genotype | en_US |
dc.subject | human | en_US |
dc.subject | major clinical study | en_US |
dc.subject | pathogenesis | en_US |
dc.subject | physical examination | en_US |
dc.subject | single nucleotide polymorphism | en_US |
dc.subject | tumor volume | en_US |
dc.title | Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Zaman, K., Bodmer, A., Pralong, F., Castiglione-Gertsch, M., [Breast cancer and obesity, a dangerous relation] (2012) Rev Med Suisse, 8, pp. 1101-1104; Garcia-Closas, M., Gunsoy, N.B., Chatterjee, N., Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer (2014) J Natl Cancer Inst, 106, p. dju305; Ito, H., Matsuo, K., Molecular epidemiology, and possible real-world applications in breast cancer (2016) Breast Cancer, 23, pp. 33-38; Ibrahim, A.S., Khaled, H.M., Mikhail, N.N., Baraka, H., Kamel, H., Cancer incidence in Egypt: results of the national population-based cancer registry program (2014) J Cancer Epedemiol, 2014, p. 437971; Li, D., Hu, C., Li, H., Survivin as a novel target protein for reducing the proliferation of cancer cells (2018) Biomed Rep, 8, pp. 399-406; Lin, T., Wan, L., Qi, X., Shi, W., Lin, J., A moderate static magnetic field enhances TRAIL-induced apoptosis by the inhibition of Cdc2 and subsequent downregulation of survivin in human breast carcinoma cells (2014) Bioelectromagnetics, 35, pp. 337-346; Motawi, T.M., Bustanji, Y., El-Maraghy, S., Taha, M.O., Al-Ghussein, M.A., Evaluation of naproxen and cromolyn activities against cancer cells viability, proliferation, apoptosis, p53 and gene expression of survivin and caspase-3 (2014) J Enzyme Inhib Med Chem, 29, pp. 153-161; Shepelev, M.V., Kopantzev, E.P., Vinogradova, T.V., Sverdlov, E.D., Korobko, I.V., hTERT and BIRC5 gene promoters for cancer gene therapy: a comparative study (2016) Oncol Lett, 12, pp. 1204-1210; Pu, F., Shao, Z., Yang, S., Association between functional variants in BIRC5/survivin gene 3? untranslated region and mRNA expression in lymphoblastoid cell lines (2015) Oncol Lett, 10, pp. 2319-2322; de Maria, S., Lo Muzio, L., Braca, A., Survivin promoter -31G/C polymorphism in oral cancer cell lines (2011) Oncol Lett, 2, pp. 935-939; Wang, Y.H., Chiou, H.Y., Lin, C.T., Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population (2009) Urology, 73, pp. 670-674; Yang, X., Xiong, G., Chen, X., Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma (2009) J Cancer Res Clin Oncol, 135, pp. 1341-1349; Jang, J.S., Kim, K.M., Kang, K.H., Polymorphisms in the survivin gene and the risk of lung cancer (2008) Lung Cancer, 60, pp. 31-39; Jha, K., Shukla, M., Pandey, M., Survivin expression and targeting in breast cancer (2012) Surg Oncol, 21, pp. 125-131; Zaffaroni, N., Pennati, M., Daidone, M.G., Survivin as a target for new anticancer interventions (2005) J Cell Mol Med, 9, pp. 360-372; Xu, Q., Liu, M., Xu, N., Zhu, H., Variation in Sp1 binding sites correlates with expression of survivin in breast cancer (2014) Mol Med Rep, 10, pp. 1395-1399; Guo, G., Zhang, Q., Yu, Z., Correlation between survivin genetic polymorphisms and lung cancer susceptibility (2015) Int J Clin Exp Pathol, 8, pp. 7426-7430; Chen, J., Cui, X., Zhou, H., Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case�control study (2013) BMC Cancer, 13, p. 356; Li, X.B., Li, S.N., Yang, Z.H., Cao, L., Duan, F.L., Sun, X.W., Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population (2013) DNA Cell Biol, 32, pp. 236-242; Aynaci, E., Coskunpinar, E., Eren, A., Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer (2013) Genet Mol Res, 12, pp. 3975-3982; Qin, C., Cao, Q., Li, P., Functional promoter -31G > C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population (2012) PLoS One, 7, p. e28829; Upadhyay, R., Khurana, R., Kumar, S., Ghoshal, U.C., Mittal, B., Role of survivin gene promoter polymorphism (-31G > C) in susceptibility and survival of esophageal cancer in northern India (2011) Ann Surg Oncol, 18, pp. 880-887; Rasool, I., Afroze, D., Wani, K.A., Role of the functional polymorphism of survivin gene (-31G/C) and risk of breast cancer in a North Indian population (2018) Clin Breast Cancer, 18, pp. e671-e676; Altiparmak, M.D., Bilgi, C.?., Dener, N.C., The effect of survivin gene promoter polymorphism on breast cancer (2014) Turk J Biol, 38, pp. 858-866; Kosti?, M., Nikoli?, N., Ili?, B., Carki?, J., Milenkovi?, S., Vukadinovi?, M., Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development (2013) Srp Arh Celok Lek, 141, pp. 304-307; Borges Bdo, N., Burbano, R.R., Harada, M.L., Survivin -31C/G polymorphism and gastric cancer risk in a Brazilian population (2011) Clin Exp Med, 11, pp. 189-193; Borbely, A.A., Murvai, M., Szarka, K., Survivin promoter polymorphism and cervical carcinogenesis (2007) J Clin Pathol, 60, pp. 303-306; Khan, S., Bennit, H.F., Turay, D., Early diagnostic value of survivin and its alternative splice variants in breast cancer (2014) BMC Cancer, 14, p. 176; Yu-qian, W., Hai-hong, Z., Peng, W., Xiang-hui, Y., Wei, K., Xian-ling, C., Expression, clinical significance and correlation of survivin and p53 in breast cancer (2013) Biotechnol Indian J, 8, pp. 1511-1514; Lv, Y.G., Yu, F., Yao, Q., Chen, J.H., Wang, L., The role of survivin in diagnosis, prognosis and treatment of breast cancer (2010) J Thorac Dis, 2, pp. 100-110; Yie, S.M., Luo, B., Ye, N.Y., Xie, K., Ye, S.R., Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA (2006) Clin Exp Metastasis, 23, pp. 279-289; Qin, Q., Zhang, C., Zhu, H., Association between survivin -31G > C polymorphism and cancer risk: meta-analysis of 29 studies (2014) J Cancer Res Clin Oncol, 140, pp. 179-188; Goksel, G., Taneli, F., Uslu, R., Serum HER-2/neu and survivin levels and their relationship to histological parameters in early-stage breast cancer (2007) J Int Med Res, 35, pp. 165-172; Guney, N., Soydine, H.O., Derin, D., Serum and urine survivin levels in breast cancer (2006) Med Oncol, 23, pp. 335-339 | |
dcterms.source | Scopus |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- avatar_scholar_128.png
- Size:
- 2.73 KB
- Format:
- Portable Network Graphics
- Description: